Lynk Pharmaceuticals Co., Ltd
Clinical trials sponsored by Lynk Pharmaceuticals Co., Ltd, explained in plain language.
-
New eczema drug shows promise in Late-Stage trial
Disease control CompletedThis study tested an experimental drug called LNK01001 in 356 adults with moderate to severe atopic dermatitis (eczema) who had not responded well to standard creams or needed stronger treatment. Participants received either the drug or a placebo, and researchers measured improve…
Phase: PHASE3 • Sponsor: Lynk Pharmaceuticals Co., Ltd • Aim: Disease control
Last updated May 26, 2026 08:54 UTC
-
New eczema ointment shows promise in early trial
Symptom relief CompletedThis study tested an experimental ointment called LNK01004 in 75 adults with moderate to severe atopic dermatitis (eczema). Participants applied the ointment twice daily for 8 weeks. The goal was to see if it safely reduces eczema severity and improves skin symptoms compared to a…
Phase: PHASE2 • Sponsor: Lynk Pharmaceuticals Co., Ltd • Aim: Symptom relief
Last updated May 26, 2026 09:01 UTC